Boehringer Ingelheim is a global research-driven pharmaceutical company with a strong focus on developing innovative therapies that improve human and animal health. Founded in 1885 and headquartered in Germany, the company places high value on scientific excellence, patient-centricity, and sustainability, working across areas such as cardiometabolic diseases, oncology, immunology, and respiratory care. Through strategic collaborations, internal R&D, and a commitment to ethical business practices, Boehringer Ingelheim aims to bring transformative treatments to patients worldwide while pursuing long-term social and environmental responsibility